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Ferguson C, Wylde LA, Benson AP, Cannon DT, Rossiter
HB. No reserve in isokinetic cycling power at intolerance during
ramp incremental exercise in endurance-trained men. J Appl
Physiol 120: 70 –77, 2016. First published November 12, 2015;
doi:10.1152/japplphysiol.00662.2015.—During whole body exer-
cise in health, maximal oxygen uptake (V˙ O2max) is typically attained
at or immediately before the limit of tolerance (LoT). At the V˙ O2max
and LoT of incremental exercise, a fundamental, but unresolved,
question is whether maximal evocable power can be increased above
the task requirement, i.e., whether there is a “power reserve” at the
LoT. Using an instantaneous switch from cadence-independent (hy-
perbolic) to isokinetic cycle ergometry, we determined maximal
evocable power at the limit of ramp-incremental exercise. We hypoth-
esized that in endurance-trained men at LoT, maximal (4 s) isokinetic
power would not differ from the power required by the task. Baseline
isokinetic power at 80 rpm (Piso; measured at the pedals) and summed
integrated EMG from five leg muscles (iEMG) were measured in 12
endurance-trained men (V˙ O2max  4.2  1.0 l/min). Participants then
completed a ramp incremental exercise test (20-25 W/min), with
instantaneous measurement of Piso and iEMG at the LoT. Piso
decreased from 788  103 W at baseline to 391  72 W at LoT,
which was not different from the required ramp-incremental flywheel
power (352  58 W; P  0.05). At LoT, the relative reduction in Piso
was greater than the relative reduction in the isokinetic iEMG (50
9 vs. 63  10% of baseline; P  0.05). During maximal ramp
incremental exercise in endurance-trained men, maximum voluntary
power is not different from the power required by the task and is
consequent to both central and peripheral limitations in evocable
power. The absence of a power reserve suggests both the perceptual
and physiological limits of maximum voluntary power production are
not widely dissociated at LoT in this population.
central fatigue; peripheral fatigue; V˙ O2max; electromyography; exer-
cise tolerance
EXERCISE INTOLERANCE IS A key determinant of quality of life and
a strong predictor of all-cause mortality (38). The ability to
sustain whole body exercise is strongly correlated with aerobic
capacity (V˙ O2max), typically assessed by cardiopulmonary mea-
surements during a progressive, incremental exercise test to the
limit of tolerance (LoT). This symptom-limited test provides a
reliable measure of (among others) the capacity for oxygen
transport and utilization available to support the muscular
energy demands of the exercise task (23, 54). While the
attainment of V˙ O2max and LoT during incremental exercise are
typically closely coincident, it is unclear whether the two
processes are linked, either directly or via common mecha-
nisms: each having both “central” and “peripheral” compo-
nents.
V˙ O2max is dependent on O2 delivery (e.g., central cardiac
output and peripheral blood flow distribution) and O2 extrac-
tion (e.g., peripheral capillary-to-myocyte O2 diffusion and
mitochondrial O2 utilization) (46, 53). For sedentary humans
exercising at sea level, the predominant limiting factor deter-
mining V˙ O2max is the peripheral capacity for O2 extraction (45).
Endurance-trained individuals, on the other hand, have prefer-
ential skeletal muscle adaptations such that a greater muscle
oxidative enzyme activity and capillarity push the predominant
limiting factor determining V˙ O2max towards the center, i.e.,
limited by cardiac output (35, 44). The point at which V˙ O2max
is reached is presumed to place increased and intolerable strain
on intramuscular metabolism for ATP production. At this point
the ability to continue exercise would necessitate either an
improvement in exercise economy (unlikely, given that both
work efficiency and economy progressively fall during high-
intensity exercise; Ref. 43) or a further increased contribution
from substrate-level phosphorylation (glycogenolysis to pro-
duce lactate or phosphocreatine breakdown), with the conse-
quential accumulation of metabolic by-products that contribute
to muscle fatigue (2). Thus one hypothesis is that V˙ O2max is
achieved at the point at which, or very soon after which,
muscular energy provision, or its consequences, limits the
ability for muscle power production (10, 11, 26, 39), and hence
determines the LoT (37). In this scenario, V˙ O2max determines
the maximum capacity for sustained power production and the
LoT.
Alternative proposals to exercise limitation at V˙ O2max are
broadly encompassed by central, neuromuscular mechanisms.
These include the influence of afferent feedback from fatiguing
muscles to limit central motor drive and/or increased spinal
inhibition of cortical drive (3, 5–7, 51); a “central governor”
integrating peripheral signals, particularly cardiac strain, to
limit the activity of the motor system (40, 41); and the mod-
ulation of muscle activity via the sense of effort (32, 34), i.e.,
recognizing the related but independent influences of the phys-
iological strain and the perception of the task on the central and
peripheral neuromuscular system. In these scenarios, the ca-
pacity for sustained muscle activation at the LoT determines
V˙ O2max.
Despite the significance of the mechanisms limiting exercise
tolerance, during whole body exercise at V˙ O2max there remains
a lack of information on the process that ultimately limits
muscle power production. A fundamental question, which
remains unresolved, is whether or not the maximum voluntary
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power producing capacity at V˙ O2max and LoT exceeds that
required by the exercise task (32). In other words, is there
capacity for a brief increase in power output at the point of
intolerance, or conversely, is the peak voluntary power at the
V˙ O2max and LoT equal to the power demands of the task?
Identifying a power reserve at LoT is consistent with the
exercise limitation residing at the capacity for sustained muscle
activation, whereas no power reserve is more consistent with
muscle metabolism and fatigue ultimately causing exercise
intolerance.
During isometric single-muscle group contractions, torque
generated during a maximal velocity contraction does not
exceed the requirement at the LoT (2, 14, 20). This is unsur-
prising given the isolated nature of the task, which should limit
strain on cardiac output and ventilation for example, thereby
isolating the fatiguing processes to be proximal to the local
musculature. During dynamic whole body exercise that elicits
peak cardiopulmonary strain and V˙ O2max, however, the com-
plexities of instantaneously implementing the isokinetic torque
measurements required for precise assessment of power pro-
ducing capacity at LoT have hampered the ability to address
this question. Using a maximum voluntary cycling power test,
Marcora and Staiano (32) reported that the power producing
capacity exceeded the demands of the task by almost threefold,
i.e., a neuromuscular “power reserve” remains at the LoT, and
exercise is limited by the perception of effort. However, this
study was criticized because it did not appropriately control for
muscle contraction velocity, which has a dramatic influence
over power production in both fresh and fatigued states (12, 13,
18, 24, 31, 33, 48). We have recently addressed this complexity
by implementing an instantaneous switch between standard
(hyperbolic) cycle ergometry control and isokinetic cycling,
which allows peak isokinetic power (Piso) to be assessed at
baseline and at the instant of intolerance (22). We found that in
a heterogeneous group of participants (aged 29 to 72 yr, and
V˙ O2max 23.5 to 62.5 ml·min1·kg1), Piso was slightly (18%),
but significantly, greater at the LoT than the demands of the
incremental exercise. However, because of the heterogeneous
characteristics of the group, it was unclear whether this small
power reserve was related to differences in aerobic capacity,
age, habitual physical activity close to V˙ O2max, or some other
factor, among the participants.
Thus the aim of this study was to test whether a “power
reserve” remains at the LoT in young endurance-trained men.
We hypothesized that, at V˙ O2max, Piso is related to the reduction
in maximal muscle activity and not different from the power
requirement of the incremental exercise task at the LoT. We
tested this hypothesis in endurance-trained men, who were well
motivated and familiarized with the sensations of maximal
exercise and more likely to be limited by central O2 delivery
rather than peripheral O2 extraction (53). Therefore, we sup-
posed that endurance-trained individuals would be better able
to demonstrate a power reserve should one exist.
METHODS
Participants and ethical approval. Twelve healthy, endurance-
trained men (means  SD; 22  1 yr; 182  8 cm; 76  8 kg)
volunteered and provided written informed consent to participate in
the study. Participants were screened with a health and physical
activity questionnaire, with individuals identified as having any
known disease excluded. All procedures were approved by the Faculty
of Biomedical and Life Sciences Ethical Committee for nonclinical
research (University of Leeds) and complied with the latest version of
the Declaration of Helsinki. Participants visited the temperature-
controlled laboratory on a maximum of two separate occasions, with
a minimum of 24 h between visits. Before each visit participants
abstained from strenuous exercise (previous 24 h), alcohol consump-
tion (24 h), and food and caffeine ingestion (3 h).
Equipment and measures. The exercise protocol was performed on
a computer-controlled electromagnetically braked cycle ergometer,
which allowed for instantaneous switching between cadence-indepen-
dent (hyperbolic) and isokinetic modes (Excalibur Sport PFM; Lode,
Groningen, The Netherlands). Power was measured at the bottom
bracket of the crank every 2° of angular rotation, where crank power
is the product of torque and instantaneous angular velocity (21, 22).
During the exercise, surface electromyography (EMG; Telemyo
2400T G2; Noraxon, Scottsdale, AZ) was measured in five muscles
(vastus lateralis, rectus femoris, vastus medialis, biceps femoris, and
lateral gastrocnemius) of the right leg at 1,500 Hz. Electrode place-
ments followed Surface Electromyography for the Non-Invasive As-
sessment of Muscle (SENIAM) guidelines. Throughout the exercise
protocol respired gases (mass spectrometer) and inspired and expired
volumes (turbine; Interface Associates, Laguna Niguel, CA) were
sampled and digitized at 50 Hz for breath-by-breath measurement of
pulmonary gas exchange and ventilatory variables (MSX; nSpire
Health, Hertford, UK). Before each test the mass spectrometer was
calibrated using two precision-analyzed gases, and the stability of the
mass spectrometer calibration was confirmed by resampling these
gases immediately after each exercise test. The turbine was calibrated
before each test using a 3-L syringe over a range of different flow
profiles. Heart rate and arterial O2 saturation were measured through-
out the protocol using the R-R interval of a 12-lead ECG (Quest;
Burdick, Washington, DC) and earlobe pulse oximetry (Biox 3745;
Ohmeda, Louisville, KY), respectively.
Exercise protocol. Following a minimum of 1-min seated rest on
the cycle ergometer, and 4 min at 20 W, participants completed 6-min
cycling at 50 W (below the lactate threshold for all participants),
immediately after which peak isokinetic power was measured at
baseline (baseline Piso in unfatigued state). Piso was measured from
the mean crank power across five maximal effort crank revolutions at
a pedaling cadence of 80 rpm. The ability of the ergometer to maintain
the target isokinetic cadence throughout this 3.75 s effort was con-
firmed post hoc. Subsequently, and after a minimum of 6 min of
recovery at 20 W (to allow for stabilization of CO2 stores; Ref. 42),
each participant performed a symptom limited ramp incremental
exercise test (20–25 W/min). The LoT was defined as the point at
which the participant was unable to maintain a cadence 55 rpm
despite strong verbal encouragement. The final five pedal strokes in
this incremental phase were analyzed to determine the crank power at
the LoT with the pedal cadence unconstrained, i.e., with the ergometer
in the hyperbolic mode (LoT Phyp). The cycle ergometer was then
instantaneously switched to isokinetic mode and the participant per-
formed a final 5 isokinetic crank revolutions at maximal effort (LoT
Piso; Fig. 1). The participant was then monitored in recovery at 20 W
for at least 4 min. Seven of the 12 participants repeated this incre-
mental-Piso test on a different day. The mean coefficient of variation
for Piso at LoT (3%) was similar to our previous report (22). As there
was no difference between LoT Piso in repeated tests, only the results
from the initial test are reported here.
Throughout the protocol, EMG signals from the five leg muscles
were recorded in 10-s bins. Specifically, EMG recordings were cap-
tured at the following time points: at the end of baseline cycling at 20
W; during the baseline Piso measurement; immediately before the
onset of the ramp incremental phase; for the final 10 s of each minute
during the ramp incremental phase; during the LoT Phyp; during the
LoT Piso; and in the final 20 s of recovery.
Data analyses. Breath-by-breath responses were edited in the V˙ O2
domain to exclude any occasional erroneous breaths (greater than
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99% of the local mean prediction limits; Ref. 30), which were
considered to be uncharacteristic of the underlying physiological
response. Lactate threshold was estimated using the V-slope relation-
ship, the end-tidal fractions of O2 and CO2, and the ventilatory
equivalents for O2 and CO2 (55). V˙ O2max was calculated as the mean
V˙ O2 for an integral number of breaths over the last 20 s before the
LoT.
Baseline Piso, LoT Phyp, and LoT Piso were each calculated as the
mean over five pedal strokes (1,800° rotation), with left and right
crank power measurements summed. In addition, the mean required
flywheel power at the LoT (i.e., the power determined by the pro-
grammed ramp incremental protocol) was calculated from the ramp
duration and the power incrementation rate.
For each of the five muscles, the EMG signals were band-pass
filtered (20–500 Hz) and rectified, with the signals from five pedal
strokes in each time period for each muscle integrated and then
summed (iEMG). The muscle selection was made to reflect the
weighted power contributions from knee flexion/extension and plantar
flexion during cycle ergometry (25). The iEMG was then used to
reflect the maximal overall muscle activation (maximal motor activ-
ity).
Statistical analysis. Power, cadence, and iEMG signals were
compared using a one-way repeated measures ANOVA, with Bonfer-
roni (cadence and iEMG), or Dunnett (power; with flywheel power
set as the reference variable for comparisons) post hoc analyses
performed where appropriate. Statistical significance was set at P 
0.05. Effect size (ES; Cohen’s d) and statistical power (	) were also
calculated for the comparisons among cycling power measurements at
the LoT. All values are reported as means  SD.
RESULTS
At the LoT of ramp incremental exercise, the flywheel
power requirement was 352  58 W, V˙ O2max was 4.2  1.0
l/(range: 3.0–6.4 l/min; 36.5–80.6 ml·min1·kg1; n 11 due
to a breath-by-breath system failure in one of the tests), and
estimated lactate threshold was 2.4  0.6 l/min (57  4%
V˙ O2max).
Power, cadence, and EMG measurements. Power and ca-
dence traces during baseline Piso, LoT Phyp, and LoT Piso are
displayed in Fig. 2 for a representative subject. The instanta-
neous pedaling cadence and the mean required flywheel power
at the LoT in the ramp incremental exercise test are shown.
Also displayed are the rectified, filtered EMG signals for the
vastus lateralis, vastus medialis, and rectus femoris during the
3.75 s of maximal effort crank revolutions.
Mean baseline Piso was 788  103 W, attained with a
measured isokinetic cadence of 80.5  0.1 rpm. The Phyp,
measured at the crank at the LoT, was 310  58 W and
occurred at 55 4 rpm (P 0.05 vs. both Piso conditions). The
LoT Piso was 391  72 W at a measured isokinetic cadence of
80.3  0.2 rpm, which was not different from the cadence
during the baseline Piso measurement (P  1.000). LoT Phyp
and LoT Piso decreased to 39 5 and 50 9% of baseline Piso,
respectively.
Neither LoT Phyp (310 58 W) nor LoT Piso (391 72 W),
both measured at the crank, were different from the flywheel
power required at the point intolerance in the incremental test
(352  58 W; LoT Piso vs. flywheel comparison, P  0.116,
ES  0.81, 	  0.73; Phyp vs. flywheel comparison, P 
0.093, ES  1.64, 	  0.90; Fig. 3). The absence of a
difference between the LoT Phyp and the required flywheel
power at the LoT validated the assumption that participants
were driving the pedals maximally in the final stages of the
ramp incremental test to the point of intolerance. The absence
of a difference between LoT flywheel power and Piso (mean:
39 48 W; range:12–105 W; equivalent to 96–135% of the
power required to maintain the incremental exercise task at
LoT) demonstrated that there was no “power reserve” at the
limit of ramp incremental cycle ergometry (Fig. 3).
There was no difference in iEMG at 20 W between
baseline (10  3%) and recovery (10  6%; P  0.813),
relative to baseline Piso iEMG (100%). The relationship
between the iEMG and Piso at the LoT (isokinetic at 80 rpm;
iEMG and Piso both normalized to the baseline Piso test) is
presented in Fig. 4. Overall, the percentage reduction in Piso
was greater than the percentage reduction in iEMG (50  9
vs. 63  10% of baseline; P  0.004). However, there were
two distinct groups: in some participants the reduction in Piso
was closely proportioned to the reduction in muscle activity
(i.e., within 10%; n 6; Fig. 5A), while in others the reduction
is Piso was greater than the reduction in muscle activity (i.e.,
10%; n  6; Fig. 5B). Nevertheless, despite the heterogene-
ity in maximal evocable muscle activity, isokinetic power
production was not different from the required flywheel power
at LoT (Fig. 3). There was a weak relationship between V˙ O2max
and the relative reduction in Piso at the limit of tolerance (r2 
0.348; P  0.057; Fig. 5C).
DISCUSSION
The aim of this study was to test whether or not a power
reserve remains at the LoT during incremental exercise in
young endurance-trained men. The major finding was that
during a 4 s maximal isokinetic cycling effort at the point of
intolerance, young endurance-trained men were unable to vol-
untarily increase power output applied to the crank above the
level required by the task. Thus the absence of a power reserve
suggests that the maximum voluntary power producing capac-
Fig. 1. Schematic of the experimental protocol. Following a period of rest and
20-W baseline pedaling, constant power exercise was performed at 50 W for
6 min, immediately followed by 5 maximal effort isokinetic crank revolutions
at 80 rpm [Œ; baseline isokinetic power (Piso)]. Following a period of recovery
at 20 W to allow for the stabilization of body CO2 stores (at least 6 min), a
ramp incremental test was performed to the limit of tolerance (LoT) with
summed integrated EMG (iEMG), with this immediately followed by 5
maximal effort isokinetic crank revolutions at 80 rpm (Œ; LoT Piso). The time
points of the iEMG measures are also shown ().
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ity at LoT is not different from the demands of the task, such
that task failure in whole body exercise at V˙ O2max is limited by
the capacity to produce the required power. We also found that,
on average, the reduction in muscle power production during a
maximal isokinetic effort was greater than the reduction in
muscle activity (from iEMG) implicating an important role
for muscle fatigue in limiting exercise tolerance at V˙ O2max in
young endurance-trained men.
Maximum voluntary power at V˙ O2max. Central to developing
an understanding of the relationships among V˙ O2max, LoT, and
fatigue is validating the assumption that maximum evocable
power is limiting at the point of intolerance. This assumption
has been challenged by evidence that at the LoT of constant
power exercise at 80% V˙ O2max, participants could generate, on
average, 500 W during a brief “Wingate” style sprint: this
was300% more power than that required by the exercise task
(32). However, in isolated muscles or muscle groups, the
relationship between power output and muscle shortening
velocity is parabolic: this relationship is maintained during
complex movements such as cycling (12, 13, 48). Therefore,
appropriate assessment of whether voluntary maximal
power is limiting, or not, requires task and velocity-specific
measurements (13, 18, 22, 24, 31) to be made instanta-
neously at the point of intolerance (1, 22, 47). We overcame
this complexity using an instantaneous switch between hy-
perbolic and isokinetic cycling, allowing us to compare
maximal voluntary power production at a fixed velocity. We
found that at the point of ramp incremental exercise intol-
erance, cycling power increased from 310  58 W (Phyp) to
391  72 W (LoT Piso) when cadence was increased from
55 rpm (Phyp) to 80 rpm (LoT Piso) but that participants
were unable to generate an isokinetic power that exceeded
the power required by the incremental exercise task (352 
58; P  0.05 vs. LoT Piso).
Using a similar approach, Coelho et al. (22) found that LoT
Piso was 55  14% of baseline Piso (i.e., a decrease in Piso,
Fig. 2. Top: instantaneous power measured in the right (solid) and left (dashed) cranks during 5 maximum effort cycling pedal strokes (3.75 s; row 1). Also
displayed are the measured instantaneous cadence (horizontal solid line) and required crank power at the limit of tolerance of the ramp incremental exercise test
(LoT; horizontal dotted line). Bottom: rectified, filtered, EMG signals from the vastus lateralis (row 2), vastus medialis (row 3), and rectus femoris (row 4) during
5 maximum effort cycling pedal strokes. Data are shown in the baseline, unfatigued, condition (baseline Piso; left) at intolerance with unrestrained cadence at
55 rpm (LoT Phyp; middle column), and at intolerance with isokinetic cadence at 80 rpm (LoT Piso; right).
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termed performance fatigue, of 45%) but that there was a
small (18  11%) significant power reserve. We found a
similar magnitude of performance fatigue in our participants
(50%), but we were unable to detect a significant power
reserve (12  15%). This dichotomy may be related to char-
acteristics of the participants in the two studies. Coelho et al.
(22) recruited young and elderly participants (29–72 yr) rang-
ing widely in habitual activity and V˙ O2max. On the other hand
we purposely recruited young endurance-trained men who
were well familiarized with the sensations associated with
sustained exercise at V˙ O2max. We hypothesized that a well-
trained group would be more likely to be limited at V˙ O2max by
“central” factors such as O2 delivery, rather than “peripheral”
variables such as O2 extraction and muscle oxidative ATP
producing capacity (53) and, therefore, would be more likely to
demonstrate a power reserve should one be present. Our
findings, therefore, are consistent with the notion that Piso
decreases during ramp incremental exercise to the point of
intolerance, at which point power-producing capacity is then
equal to the demands of the exercise task.
A schematic of this notion is shown in Fig. 6. The dynamics
of performance fatigue are typically shown to be approxi-
mately linear during isolated muscle tasks (14, 20) or curvi-
linear (rapid at the onset and slower as time progresses) for
constant power tasks using isolated muscle groups (27, 29), but
the dynamics of performance fatigue for whole body incremen-
tal exercise are less well known. Using interleaved maximal
isokinetic efforts, Cannon et al. (21), demonstrated that exer-
cise below the lactate threshold was not associated with a
reduction in peak power but exercise above the lactate thresh-
old was associated with fatigue. Therefore, the schematic in
Fig. 6 assumes that performance fatigue develops only once the
lactate threshold is exceeded (21). As whole body exercise
progresses, performance fatigue increases until the power pro-
ducing capacity equals the exercise task. In other words,
exercise is terminated at the point of interception between Piso
(Fig. 6, dashed line) and the required flywheel power (Fig. 6,
solid line), with no power reserve (cf. Ref. 2).
We combined the data from this study with those of Coelho
et al. (22) to demonstrate that across a wide range of aerobic
function (i.e., untrained participants in Coelho et al. and en-
durance-trained participants in this study) there is a weak
significant relationship between V˙ O2max and performance fa-
tigue (the relative reduction in Piso; r2  0.210; P  0.021).
This is consistent with the suggestion that aerobic capacity
protects against fatigue-induced reductions in power output,
allowing incremental exercise to continue until a greater pro-
portion of baseline Piso has been accessed. While speculative,
this protection from performance fatigue may be a conse-
quence of a reduced requirement for intramuscular substrate-
level phosphorylation at any given power, slowing the rate of
accumulation of metabolites associated with peripheral fatigue
development (such as inorganic phosphate; Refs. 2, 36), and/or
a greater proportion of fatigue resistant muscle fibers with high
oxidative capacity engaged in the exercise (8, 9).
The absence of a power reserve is consistent with the
suggestion that during dynamic whole body exercise in endur-
ance-trained individuals, in which rates of O2 delivery and
utilization are at, or near, maximum, the perceptual and phys-
iological limits of the exercise are not significantly dissociated
at intolerance (cf. Ref. 32). Whether this assertion holds true
for different whole body exercise protocols (e.g., short vs.
sustained tasks) or in different participant populations (e.g.,
patients with chronic cardiovascular or pulmonary disease)
remains to be determined.
Mechanisms of exercise intolerance in whole body exercise.
The reduction in maximal voluntary muscle activation
(iEMG) confirms the important role for reductions in central
motor drive (i.e., central fatigue) and/or spinal inhibition of
cortical drive in performance fatigue (3, 5–7, 20, 22, 29, 51).
The approach used in this study is unable to isolate whether
this reduction in motor activity occurs at the level of cortical
Fig. 3. Mean and individual (Œ) isokinetic power at baseline (baseline Piso),
crank power at the limit of tolerance (LoT Phyp; variable cadence, 55 rpm),
and isokinetic power at the limit of tolerance (LoT Piso; 80 rpm) relative to the
required flywheel power at the limit of tolerance of the ramp incremental
exercise test (dashed horizontal line). *Significant difference from the required
flywheel power at the limit of tolerance using Dunnett’s post hoc with flywheel
power set as the reference variable.
Fig. 4. Relationship between the reduction in the summed integrated electro-
myography (LoT iEMG) from 5 leg muscles and isokinetic power (LoT Piso)
at the limit of tolerance of ramp incremental exercise. Œ, Participants in whom
the reduction in Piso was within 10% of the reduction in iEMG; , partici-
pants in whom the reduction in Piso was at least 10% greater than the reduction
in iEMG. The data are normalized to baseline Piso. Solid line, y  x; dashed
line, (y  10%)  x.
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output (central motor drive), spinal inhibition, or excitation-
contraction coupling. However, it is of relevance that Coelho et
al. (22) recently demonstrated the relationship between muscle
activity and power production during isokinetic cycling is
linear, allowing us to make some inferences based on changes
in the iEMG-Piso relationship between baseline and intoler-
ance. We found, overall, that the relative reduction in Piso was
greater than the relative reduction in iEMG (Figs. 4 and 5, A
and B), suggesting that muscle fatigue and reduced muscle
activity combine to reduce maximal evocable power. Afferent
feedback from fatiguing muscle is known to reduce spinal
excitability and inhibit motor activation (6, 7, 29, 49, 50).
While half (n  6) of our participants showed an iEMG-Piso
relationship consistent with a large contribution of muscle
fatigue to performance fatigue (similar to Ref. 22), the LoT in
the other six participants was strongly associated with the
reduction in iEMG alone. The reasons for this variability
among individual responses are currently unclear, but these
data emphasize how little is understood about the interactions
between overt muscle fatigue and the reduction in muscle
activation that combine to bring about intolerance during
whole body exercise.
It is uncommon for muscle fatigue (e.g., assessed by twitch
force measurement) to exceed a given threshold within any
individual and task (3, 4, 7, 20, cf. 6, 28), despite interventions
that alter the rate at which fatigue-related metabolites are
accumulated, such as the magnitude of the external power
above the critical power asymptote (19, 52), arterial oxygen
concentration (4, 52), preexisting muscle fatigue (3, 26), or
manipulations of blood flow (16, cf. 15, 17). The implication of
this “fixed threshold” of muscle fatigue is that the absence of
a power reserve at LoT requires that central fatigue must be
variable during protocols that differ in duration (20) or during
exercise in hypoxia (4, 52). This seems at odds with our
observation that at LoT some participants show features of the
iEMG-Piso relationship that are consistent with a large com-
ponent of muscle fatigue, and others with a large component of
central fatigue, but all reach the point where external power
can no longer meet the demand. Amplification of the central
fatigue component for a given level of muscle fatigue may
occur during prolonged exercise (20, 49); however, in our
study the ramp duration was similar for all participants. Thus,
while it seems there was a variable combination of central and
peripheral mechanisms that limited whole body exercise in this
study, this was neither associated with a peripheral fatigue
“threshold” nor a difference among individuals in the physio-
logical limits to performance and the perceptual limits of the
task during incremental exercise to V˙ O2max in endurance-
trained young men.
Limitations. A potential limitation of this study is the low
number of participants, which could limit the ability to
detect a power reserve should one exist. The ES (0.81) and
moderate 	 (0.73) for the comparison between flywheel
power and Piso at the LoT provide some potential for a type
II error in the interpretation that there was no power reserve
at the LoT. However, an important consideration is the
physiological importance of any potential difference in Piso
and flywheel power. In an attempt to contextualize the ES
we measured the 95% confidence interval of mean fluctua-
tions in crank power during the entire ramp incremental
protocol (21.5% of the flywheel power), i.e., brief fluctu-
ations in power production are observed in “normal” cycling
and vary by 20%. Therefore, we suggest that any power
reserve would need to exceed this ‘normal’ fluctuation
Fig. 5. Relationship between crank power and iEMG in 2 individual participants during the ramp incremental exercise test (Œ; variable cadence) relative to
isokinetic power measured at baseline (; baseline Piso). Also displayed is the isokinetic power measured at the limit of tolerance of ramp incremental exercise
(Œ; LoT Piso). A: representative participant where the fatigue-induced reduction in Piso appears closely proportional to the reduction in iEMG. B: representative
participant where the relative fatigue-induced reduction in Piso is greater than the reduction in iEMG. Also displayed in C is the relationship between V˙ O2max
(n  11) and the reduction in Piso at the limit of tolerance (LoT Piso), normalized to baseline Piso. The solid line is the linear regression of this relationship
(r2  0.348; P  0.057).
Fig. 6. Hypothesized schematic of the relationship between the ramp incre-
mental power (solid line) and fall in maximal isokinetic power (Piso; dashed
line) once this exceeds the lactate threshold. Also displayed is the isokinetic
power measured at the limit of tolerance (; %baseline Piso). When Piso
matches the demands of the exercise task (i.e., the intercept of the solid and
dashed lines), the LoT is attained with no significant reserve in maximal
cycling power.
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(20%) to be considered physiologically important. How-
ever, our participants could only produce a 12% increase in
power between flywheel demand and Piso at LoT. Therefore,
we believe that the observation in this study is a valid
reflection of the absence of a power reserve at LoT.
Conclusion. In endurance-trained participants at the V˙ O2max
and LoT of ramp incremental exercise, maximum voluntary
isokinetic cycling power is reduced to a value not different
from the flywheel power required by the task. The absence of
a power reserve is consistent with the assertion that the per-
ceptual and physiological limits of maximum voluntary power
production are not widely dissociated at the LoT in this
population.
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